Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) EBITDA (2016 - 2025)

Historic EBITDA for Phibro Animal Health (PAHC) over the last 14 years, with Q4 2025 value amounting to $50.3 million.

  • Phibro Animal Health's EBITDA rose 9710.18% to $50.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $168.8 million, marking a year-over-year increase of 10695.7%. This contributed to the annual value of $110.5 million for FY2025, which is 10719.31% up from last year.
  • According to the latest figures from Q4 2025, Phibro Animal Health's EBITDA is $50.3 million, which was up 9710.18% from $51.3 million recorded in Q3 2025.
  • In the past 5 years, Phibro Animal Health's EBITDA registered a high of $51.3 million during Q3 2025, and its lowest value of -$726000.0 during Q3 2023.
  • Moreover, its 5-year median value for EBITDA was $19.6 million (2022), whereas its average is $22.8 million.
  • As far as peak fluctuations go, Phibro Animal Health's EBITDA plummeted by 10530.55% in 2023, and later surged by 253787.88% in 2024.
  • Over the past 5 years, Phibro Animal Health's EBITDA (Quarter) stood at $22.3 million in 2021, then fell by 28.93% to $15.8 million in 2022, then decreased by 0.9% to $15.7 million in 2023, then soared by 62.62% to $25.5 million in 2024, then skyrocketed by 97.1% to $50.3 million in 2025.
  • Its EBITDA stands at $50.3 million for Q4 2025, versus $51.3 million for Q3 2025 and $33.7 million for Q2 2025.